Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Thanks to a $28 million grant, Harvard is heavily researching artificial intelligence

Add as a preferred source on Google

Some of the most intelligent minds in the country are taking a closer look at artificial intelligence, and if the student surpasses the master in this scenario, the world will have some pretty impressive machines on its hands. The Intelligence Advanced Research Projects Activity (IARPA), a government institution that concerns itself with large-scale research efforts, has awarded a $28 million grant to Harvard’s John A. Paulson School of Engineering and Applied Sciences (SEAS), Harvard’s Center for Brain Science (CBS), and its Department of Molecular and Cellular Biology. The sizable grant to these three departments is meant to help the famed Boston institution develop “advanced machine learning algorithms by pushing the frontiers of neuroscience.”

The goal of the latest research effort is to better understand the human brain so that machines may emulate our biological capabilities. Today, our minds and our machines each excel at two differing functions — while humans are able to quickly recognize patterns and learn, machines are far better at processing large amounts of data. The sweet spot, then, would be to design an AI that can not only learn as well as humans can, but do so with the speed of a robot.

Recommended Videos

“This is a moonshot challenge, akin to the Human Genome Project in scope,” said project leader David Cox, assistant professor of molecular and cellular biology and computer science. “The scientific value of recording the activity of so many neurons and mapping their connections alone is enormous, but that is only the first half of the project,” Cox continued. “As we figure out the fundamental principles governing how the brain learns, it’s not hard to imagine that we’ll eventually be able to design computer systems that can match, or even outperform, humans.”

Of course, if the project proves to be too successful,  the Harvard researchers conducting it could turn out to be the last people on earth who are gainfully employed.

Lulu Chang
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more